• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节RNA聚合酶II转录延伸活性的因素。

Factors regulating the transcriptional elongation activity of RNA polymerase II.

作者信息

Shilatifard A

机构信息

Department of Biochemistry, St. Louis University School of Medicine, St. Louis, Missouri 63104, USA.

出版信息

FASEB J. 1998 Nov;12(14):1437-46. doi: 10.1096/fasebj.12.14.1437.

DOI:10.1096/fasebj.12.14.1437
PMID:9806752
Abstract

The synthesis of mature and functional messenger RNA by eukaryotic RNA polymerase II (Pol II) is a complex, multistage process requiring the cooperative action of many cellular proteins. This process, referred to collectively as the transcription cycle, proceeds via five stages: preinitiation, initiation, promoter clearance, elongation, and termination. During the past few years, fundamental studies of the elongation stage of transcription have demonstrated the existence of several families of Pol II elongation factors governing the activity of Pol II. It is now clear that the elongation stage of transcription is a critical stage for the regulation of gene expression. In fact, two of these elongation factors, ELL and elongin, have been implicated in human cancer. This article will review the proteins involved in the regulation of the elongation stage of transcription by Pol II, describing the recent experimental findings that have propelled vigorous research on the properties and function of the elongating RNA polymerase II. --Shilatifard, A. Factors regulating the transcriptional elongation activity of RNA polymerase II.

摘要

真核生物RNA聚合酶II(Pol II)合成成熟且具有功能的信使RNA是一个复杂的多阶段过程,需要许多细胞蛋白的协同作用。这个过程统称为转录循环,通过五个阶段进行:起始前、起始、启动子清除、延伸和终止。在过去几年中,对转录延伸阶段的基础研究表明,存在几个控制Pol II活性的Pol II延伸因子家族。现在很清楚,转录延伸阶段是基因表达调控的关键阶段。事实上,其中两个延伸因子ELL和elongin与人类癌症有关。本文将综述参与Pol II转录延伸阶段调控的蛋白质,描述最近推动对延伸中的RNA聚合酶II的特性和功能进行深入研究的实验发现。——希拉蒂法德,A. 调节RNA聚合酶II转录延伸活性的因子

相似文献

1
Factors regulating the transcriptional elongation activity of RNA polymerase II.调节RNA聚合酶II转录延伸活性的因素。
FASEB J. 1998 Nov;12(14):1437-46. doi: 10.1096/fasebj.12.14.1437.
2
Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II.延伸蛋白(SIII):RNA聚合酶II延伸过程的多亚基调节因子。
Science. 1995 Sep 8;269(5229):1439-43. doi: 10.1126/science.7660129.
3
The RNA polymerase II general elongation complex.RNA聚合酶II通用延伸复合物
Biol Chem. 1998 Jan;379(1):27-31. doi: 10.1515/bchm.1998.379.1.27.
4
The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.可诱导的延伸蛋白A延伸激活结构域:结构、功能及其与延伸蛋白BC复合物的相互作用。
EMBO J. 1996 Oct 15;15(20):5557-66.
5
Characterization of elongin C functional domains required for interaction with elongin B and activation of elongin A.与延伸因子B相互作用及激活延伸因子A所需的延伸因子C功能结构域的鉴定
J Biol Chem. 1996 Oct 11;271(41):25562-8. doi: 10.1074/jbc.271.41.25562.
6
Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo.果蝇ELL在体内与转录活性位点上正在积极延伸的RNA聚合酶II相关联。
EMBO J. 2001 Nov 1;20(21):6104-14. doi: 10.1093/emboj/20.21.6104.
7
An RNA polymerase II elongation factor encoded by the human ELL gene.一种由人类ELL基因编码的RNA聚合酶II延伸因子。
Science. 1996 Mar 29;271(5257):1873-6. doi: 10.1126/science.271.5257.1873.
8
Interaction of von Hippel-Lindau tumor suppressor gene product with elongin.冯·希佩尔-林道肿瘤抑制基因产物与延伸蛋白的相互作用。
Methods Enzymol. 1996;274:436-41. doi: 10.1016/s0076-6879(96)74035-1.
9
Mechanism and regulation of transcriptional elongation and termination by RNA polymerase II.RNA聚合酶II转录延伸与终止的机制及调控
Curr Opin Genet Dev. 1997 Apr;7(2):199-204. doi: 10.1016/s0959-437x(97)80129-3.
10
Transcription elongation and human disease.转录延伸与人类疾病。
Annu Rev Biochem. 1999;68:301-19. doi: 10.1146/annurev.biochem.68.1.301.

引用本文的文献

1
Sequence, structural and functional conservation among the human and fission yeast ELL and EAF transcription elongation factors.人类和裂殖酵母 ELL 和 EAF 转录延伸因子在序列、结构和功能上的保守性。
Mol Biol Rep. 2022 Feb;49(2):1303-1320. doi: 10.1007/s11033-021-06958-x. Epub 2021 Nov 22.
2
Epigenetics of hematopoiesis and hematological malignancies.造血作用与血液系统恶性肿瘤的表观遗传学
Genes Dev. 2016 Sep 15;30(18):2021-2041. doi: 10.1101/gad.284109.116.
3
A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency.
一小部分超级延伸复合物在逆转HIV-1潜伏中起主要作用。
Mol Cell Biol. 2016 Feb 1;36(7):1194-205. doi: 10.1128/MCB.00994-15.
4
MYB elongation is regulated by the nucleic acid binding of NFκB p50 to the intronic stem-loop region.MYB基因的延伸受NFκB p50与内含子茎环区域的核酸结合调控。
PLoS One. 2015 Apr 8;10(4):e0122919. doi: 10.1371/journal.pone.0122919. eCollection 2015.
5
Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response.转录延伸因子ELL2驱动Ig分泌特异性mRNA的产生和未折叠蛋白反应。
J Immunol. 2014 Nov 1;193(9):4663-74. doi: 10.4049/jimmunol.1401608. Epub 2014 Sep 19.
6
A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance.FBXO38 中的显性突变导致以小腿为主的远端型脊肌萎缩症。
Am J Hum Genet. 2013 Nov 7;93(5):976-83. doi: 10.1016/j.ajhg.2013.10.006. Epub 2013 Oct 24.
7
The little elongation complex functions at initiation and elongation phases of snRNA gene transcription.小延伸复合物在 snRNA 基因转录的起始和延伸阶段发挥作用。
Mol Cell. 2013 Aug 22;51(4):493-505. doi: 10.1016/j.molcel.2013.07.003. Epub 2013 Aug 8.
8
Transcriptional elongation checkpoint control in development and disease.发育与疾病中的转录延伸检查点控制。
Genes Dev. 2013 May 15;27(10):1079-88. doi: 10.1101/gad.215137.113.
9
The super elongation complex (SEC) family in transcriptional control.转录控制中的超级延伸复合物(SEC)家族。
Nat Rev Mol Cell Biol. 2012 Sep;13(9):543-7. doi: 10.1038/nrm3417. Epub 2012 Aug 16.
10
The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.COMPASS 家族的组蛋白 H3K4 甲基转移酶:在发育和疾病发病机制中的调控机制。
Annu Rev Biochem. 2012;81:65-95. doi: 10.1146/annurev-biochem-051710-134100.